BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 16969021)

  • 1. [Clinical efficacy and safety of weekly paclitaxel therapy as second-line chemotherapy for patients with advanced and recurrent gastric cancer who were previously treated with TS-1 therapy].
    Hatori S; Kunisaki C; Ono H; Sato T; Otsuka Y; Yamada R; Ohshima T; Rino Y; Imada T
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1257-60. PubMed ID: 16969021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Low-dose paclitaxel therapy as second-line chemotherapy for patients who previously received TS-1 therapy].
    Takemura M; Osugi H; Lee S; Kaneko M; Tanaka Y; Fujiwara Y; Nishizawa S; Iwasaki H
    Gan To Kagaku Ryoho; 2004 Dec; 31(13):2183-6. PubMed ID: 15628768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Weekly administration of paclitaxel as a second-line chemotherapy for advanced and recurrent gastric cancer].
    Makari Y; Fujiwara Y; Yasuda T; Takiguchi S; Kimura Y; Yano M; Monden M
    Gan To Kagaku Ryoho; 2004 Apr; 31(4):609-11. PubMed ID: 15114710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Safety and efficacy of chemotherapy using TS-1 followed by paclitaxel for advanced or recurrent gastric cancer with peritoneal dissemination].
    Ohashi M; Kanda T; Yajima K; Banba T; Tanabe T; Kosugi S; Hatakeyama K
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1640-2. PubMed ID: 16315894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case responding to weekly paclitaxel therapy as second-line chemotherapy for gastric cancer previously treated with TS-1].
    Imamura H; Furukawa H; Kishi K; Tatsuta M; Masutani S; Fukunaga M; Nakayama T; Shimizu J; Takemoto H; Kishimoto T; Kato H; Yamamoto K; Fujishima M; Kawasaki T
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1693-5. PubMed ID: 15553685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of stage IV gastric cancer previously treated with TS-1 completely responding to second-line chemotherapy with weekly paclitaxel therapy].
    Jingu K; Sasagawa K; Kagaya A; Ochiai T
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2117-20. PubMed ID: 16352940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical results of single therapy with TS-1 for advanced/recurrent gastric cancer].
    Ohshima T; Yamada R; Hatori S; Kunisaki C; Makino T; Yamazaki Y; Suda T; Rino Y; Takanashi Y; Imada T
    Gan To Kagaku Ryoho; 2006 Aug; 33(8):1105-10. PubMed ID: 16912529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Three cases of advanced and recurrent gastric cancer treated with paclitaxel after TS-1 administration].
    Fujiwara Y; Tamura S; Yoshioka S; Okada Y; Takiguchi S; Yano M; Yasuda T; Monden M
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2555-9. PubMed ID: 12506482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second-line chemotherapy with biweekly paclitaxel after failure of fluoropyrimidine-based treatment in patients with advanced or recurrent gastric cancer: a report from the gastrointestinal oncology group of the Tokyo cooperative oncology group, TCOG GC-0501 trial.
    Koizumi W; Akiya T; Sato A; Yamaguchi K; Sakuyama T; Nakayama N; Tanabe S; Higuchi K; Sasaki T; Sekikawa T;
    Jpn J Clin Oncol; 2009 Nov; 39(11):713-9. PubMed ID: 19812061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination of S-1 and paclitaxel for advanced/recurrent gastric cancer patients with peritoneal metastasis, feasibility study (OGSG0401)].
    Kimura Y; Machida H; Fujitani K; Yamamoto M; Tominaga K; Yano H; Shimokawa T; Takiuchi H; Tsujinaka T; Furukawa H
    Gan To Kagaku Ryoho; 2010 Jan; 37(1):151-5. PubMed ID: 20087052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Weekly administration regimen of paclitaxel (PTX) in patient with inoperable or recurrent gastric cancer].
    Kii T; Takiuchi H; Gotoh M; Kawabe S; Ohta S; Tanaka T; Kuwakado S; Nishitani H; Katsu K
    Gan To Kagaku Ryoho; 2006 May; 33(5):621-4. PubMed ID: 16685160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Weekly administration of paclitaxel with a short course of premedication for advanced or recurrent gastric cancer].
    Yamamoto S; Tanaka Y; Ito T; Nakai S; Morimoto Y; Kitagawa T; Kurihara Y; Nishimura J
    Gan To Kagaku Ryoho; 2003 Jan; 30(1):67-71. PubMed ID: 12557707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I study of a combination of s-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer.
    Ueda Y; Yamagishi H; Ichikawa D; Morii J; Koizumi K; Kakihara N; Shimotsuma M; Takenaka A; Yamashita T; Kurioka H; Nishiyama M; Morita S; Nakamura K; Sakamoto J
    Oncology; 2005; 69(3):261-8. PubMed ID: 16138002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of S-1-resistant recurrent gastric cancer successfully treated with weekly administration of paclitaxel].
    Takashima T; Ito T; Sato T; Hirata K
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1103-6. PubMed ID: 17637549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A phase I study of combination chemotherapy using TS-1 and weekly paclitaxel for advanced gastric cancer].
    Fujiwara Y; Fujita J; Kan K; Tsukahara K; Takiguchi S; Miyata H; Yasuda T; Doki Y; Monden M
    Gan To Kagaku Ryoho; 2006 Jan; 33(1):45-8. PubMed ID: 16410697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Usefulness of weekly administration of paclitaxel for advanced or recurrent gastric cancer].
    Egawa T; Kubota T; Nagashima A; Doi M; Kitano M; Hayashi S; Yoshii H; Saikawa Y; Kitajima M
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):877-81. PubMed ID: 15222104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of recurrent gastric cancer with peritoneal dissemination successfully treated with DJ stents against bilateral hydronephrosis and chemotherapy].
    Ebisui C; Souma I; Hayashi N; Fukuchi N; Izawa H; Yoshida T; Sakita I; Hasuike Y; Fujimoto T
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1861-3. PubMed ID: 15553740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-center phase II study of S-1 plus paclitaxel as first-line therapy for patients with advanced or recurrent unresectable gastric cancer.
    Lee JJ; Kim SY; Chung HC; Lee KH; Song HS; Kang WK; Hong YS; Choi IS; Lee YY; Woo IS; Choi JH
    Cancer Chemother Pharmacol; 2009 May; 63(6):1083-90. PubMed ID: 18813927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Feasibility study of weekly paclitaxel as second-line chemotherapy against 5-FU-refractory gastric carcinoma].
    Ito S; Kodera Y; Mochizuki Y; Yamamura Y
    Gan To Kagaku Ryoho; 2005 Oct; 32(10):1427-30. PubMed ID: 16227742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of advanced gastric cancer treated with S-1 and S-1/paclitaxel showing complete response twice].
    Matsuyama J; Naitou A; Hiraki M; Matsumoto S; Hashimoto K; Yokoyama S; Morita S; Morimoto T; Fukushima Y; Nishishou I; Nomura T; Sasaki Y
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2297-9. PubMed ID: 20037401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.